SPY is an exchange-traded fund (ETF) that aims to replicate the performance of the S&P 500 Index. The S&P 500 Index includes 500 of the largest publicly traded companies in the United States, representing a broad cross-section of the U.S. economy.
Metrics and analysis →BIO
Biogen Inc. is a biotechnology company focused on developing therapies for neurological diseases, including multiple sclerosis and spinal muscular atrophy.
- Open
- 356.70
- High
- 369.44
- Low
- 353.31
- Prev close
- 367.50
- Volume
- 174K
- Avg vol 10
- 285K
Today · Market closed · opens Mon 9:30 AM
BIO chart
Scroll or pinch to zoom, drag to pan, or use the buttons on the chart. About the price history
Technical analysis
Daily bars · last bar Nov 20, 2026 · close 358.90
Leaning sell. 6 of 18 signals point down against 2 up, carried by momentum and trend. Volatility is mostly neutral. Volume is mostly neutral. Stochastic, Williams %R and CCI sit in oversold territory. Trend strength is weak (ADX 14).
Trend
Momentum
Volatility
Volume
Leaning sell. The close is above 8 of 24 averages and below 16. Price is below the short-term averages (5 to 20) and above the long-term ones (50 to 200). SMA 50 is above SMA 200 (371.63 vs 318.59).
| Period | SMA | EMA | WMA | WEMA |
|---|---|---|---|---|
| 5 | 363.00 | 364.61 | 363.44 | 367.41 |
| 10 | 371.26 | 367.91 | 366.54 | 370.02 |
| 20 | 373.97 | 370.12 | 371.30 | 369.78 |
| 50 | 371.63 | 368.07 | 370.68 | 355.42 |
| 100 | 357.00 | 355.11 | 368.74 | 334.92 |
| 200 | 318.59 | 335.25 | 341.36 | 317.56 |
Green: the close is above that average. Red: below it.
From the bar before the last one. Nearest classic support is S2 at 356.39. Nearest resistance is S1 at 361.94.
| Level | Classic | Fibonacci | Camarilla | Floor | Woodie | DeMark |
|---|---|---|---|---|---|---|
| R3 | 403.97 | 388.11 | 371.86 | 393.66 | 388.13 | — |
| R2 | 388.11 | 382.05 | 370.41 | 388.11 | 385.34 | — |
| R1 | 377.80 | 378.31 | 368.95 | 377.80 | 372.27 | 375.03 |
| Pivot | 372.25 | 372.25 | 372.25 | 372.25 | 369.48 | 370.86 |
| S1 | 361.94 | 366.19 | 366.05 | 361.94 | 356.41 | 359.17 |
| S2 | 356.39 | 362.45 | 364.59 | 356.39 | 353.62 | — |
| S3 | 340.53 | 356.39 | 363.14 | 346.08 | 340.55 | — |
Patterns that formed on the last 5 bars, newest first.
A long up candle, then a down candle that opens above its high and closes more than halfway down its body.
Buyers were pushed back hard after a new high; a turn down may follow.
A long candle with no shadows: it opened at one extreme and closed at the other.
Buyers controlled the bar from open to close.
A small body with shadows longer than the body on both sides.
Neither side won the bar. On its own it says little; after a strong move it warns the move is tiring.
A long-legged doji with the body near the middle of the range.
Neither side won the bar. On its own it says little; after a strong move it warns the move is tiring.
A candle with a short body and short shadows: a quiet bar.
A small loss on little range; weak on its own.
How candlestick references usually rate the pattern. It is not a success rate measured on this ticker. About candle patterns
| Date | Open | High | Low | Close | Volume | Change |
|---|---|---|---|---|---|---|
| Nov 20, 2026 | 364.34 | 369.44 | 353.31 | 358.90 | 182K | −5.44 |
| Nov 19, 2026 | 373.35 | 382.55 | 366.69 | 367.50 | 424K | −5.85 |
| Nov 18, 2026 | 358.00 | 370.65 | 358.00 | 370.17 | 461K | +12.17 |
| Nov 17, 2026 | 359.39 | 361.69 | 356.50 | 358.19 | 203K | −1.20 |
| Nov 16, 2026 | 363.83 | 365.61 | 358.49 | 360.26 | 170K | −3.57 |
| Nov 13, 2026 | 370.19 | 373.50 | 364.11 | 366.36 | 256K | −3.83 |
| Nov 12, 2026 | 382.88 | 390.00 | 369.40 | 370.48 | 182K | −12.40 |
| Nov 11, 2026 | 388.31 | 389.99 | 382.76 | 386.00 | 212K | −2.31 |
| Nov 10, 2026 | 386.92 | 390.44 | 381.77 | 386.48 | 211K | −0.44 |
| Nov 9, 2026 | 385.38 | 394.73 | 381.59 | 388.31 | 547K | +2.93 |
| Nov 6, 2026 | 364.45 | 384.62 | 363.59 | 381.57 | 273K | +17.12 |
| Nov 5, 2026 | 367.29 | 375.07 | 352.09 | 369.00 | 434K | +1.71 |
| Nov 4, 2026 | 380.05 | 382.00 | 371.54 | 379.99 | 282K | −0.06 |
| Nov 3, 2026 | 369.45 | 376.81 | 369.45 | 374.91 | 214K | +5.46 |
| Nov 2, 2026 | 374.79 | 377.90 | 361.27 | 366.16 | 212K | −8.63 |
| Oct 30, 2026 | 381.09 | 384.00 | 368.45 | 372.18 | 183K | −8.91 |
| Oct 29, 2026 | 389.15 | 390.16 | 379.24 | 384.40 | 332K | −4.75 |
| Oct 28, 2026 | 384.15 | 388.86 | 379.79 | 385.12 | 251K | +0.97 |
| Oct 27, 2026 | 376.25 | 381.87 | 369.33 | 380.99 | 167K | +4.74 |
| Oct 26, 2026 | 371.80 | 376.00 | 369.76 | 372.43 | 179K | +0.63 |
| Oct 23, 2026 | 356.98 | 371.31 | 352.46 | 369.95 | 167K | +12.97 |
| Oct 22, 2026 | 359.83 | 367.93 | 359.83 | 363.50 | 228K | +3.67 |
| Oct 21, 2026 | 350.21 | 362.42 | 347.29 | 360.50 | 361K | +10.29 |
| Oct 20, 2026 | 352.08 | 356.93 | 350.49 | 354.50 | 212K | +2.42 |
| Oct 19, 2026 | 355.30 | 356.34 | 350.61 | 352.82 | 221K | −2.48 |
| Oct 16, 2026 | 369.37 | 369.37 | 350.77 | 353.70 | 208K | −15.67 |
| Oct 15, 2026 | 364.90 | 368.54 | 359.88 | 364.82 | 248K | −0.08 |
| Oct 14, 2026 | 367.86 | 371.07 | 361.27 | 362.43 | 297K | −5.43 |
| Oct 13, 2026 | 369.00 | 369.43 | 358.43 | 363.73 | 133K | −5.27 |
| Oct 12, 2026 | 369.85 | 369.85 | 359.41 | 364.42 | 181K | −5.43 |
Performance
Daily returns for Jan 1, 2026 – Nov 22, 2026 (YTD). About the returns · About the risk figures
1 month return
-1.27%
Change in value over the past month.
3 month return
-5.99%
Change in value over the last three months.
Max drawdown
25.74%
Largest fall from a peak to the low that followed.
Standard deviation
37.49%
How far daily returns stray from their average, annualised.
Sharpe ratio
0.67
Return above the risk-free rate per unit of volatility.
Calmar ratio
0.98
Annualised return against the maximum drawdown.
BIO summary
Loading summary…
BIO, answered
What is Biogen’s role in the Alzheimer’s disease community?
Biogen plays a significant role in the Alzheimer’s disease community by developing potential treatments and supporting research efforts.
Where is Biogen headquartered?
Biogen is headquartered in Cambridge, Massachusetts, USA.
How can I find information about Biogen’s clinical trials?
Information about Biogen’s clinical trials can be found on their website and through clinical trial registries.
Is Biogen involved in research and development?
Yes, Biogen invests heavily in research and development to discover and develop new therapies for neurological conditions.
What is Biogen’s commitment to sustainability?
Biogen is committed to sustainability and aims to reduce its environmental impact through various initiatives, including reducing greenhouse gas emissions.
What is the stock performance of Biogen?
You can check Biogen’s stock performance on financial news websites and stock market platforms.
How can I access Biogen’s financial reports?
Biogen’s financial reports are available on their investor relations website, including quarterly and annual reports.
How can I stay updated on Biogen’s news?
You can stay updated on Biogen’s news by subscribing to their newsletter and following them on social media.
Does Biogen have any partnerships?
Biogen collaborates with various academic and industry partners to advance its research and development efforts.
How can I contact Biogen investor relations?
You can contact Biogen investor relations through their official website for inquiries related to the company’s financial performance.
BIO in the news
Top market assets
Discover our curated selection of top-performing exchange-traded funds (ETFs) that represent a diverse range of investment opportunities.
QQQ is an exchange-traded fund (ETF) that tracks the performance of the Nasdaq-100 Index. This index includes 100 of the largest non-financial companies listed on the Nasdaq Stock Market, primarily focusing on technology and innovation sectors.
Metrics and analysis →DIA is an exchange-traded fund (ETF) that aims to track the performance of the Dow Jones Industrial Average (DJIA). The DJIA is a stock market index consisting of 30 large, publicly traded companies in the United States, representing a broad range of industries.
Metrics and analysis →IWM is an exchange-traded fund (ETF) that seeks to track the performance of the Russell 2000 Index. The Russell 2000 Index measures the performance of the 2,000 smallest stocks in the Russell 3000 Index, representing a broad segment of small-cap U.S. companies.
Metrics and analysis →Maximize Your BIO Trading Now
Empower your trading with OHLCX execution platform. Our comprehensive platform delivers precise analysis and strategic insights for BIO, designed to improve your trading outcomes. Boost your investment success with us and unlock new opportunities with our advanced system!
Disclaimers
The information displayed on this site is sourced from third-party providers and is believed to be reliable. OHLCX has not independently verified this data and does not guarantee its accuracy. Content is for educational and informational purposes only and is not financial or investment advice.
With any investment, your capital is at risk. Past performance is no guarantee of future results. Consult your provider's terms and privacy policies where applicable.
Prices, charts and every figure derived from them are delayed by at least 15 minutes and are provided for information only; we do not guarantee their accuracy or timeliness.
Securities products are: Not FDIC insured · Not bank guaranteed · May lose value
Trademarks and logos are the property of their respective owners and do not represent endorsements of any kind.